Question: why is amrn stock down?
Answer: Amarin Stock Is Sinking After a Bearish Assessment of Its Heart Drug. Shares of the biotech firm Amarin was down more than 4% shortly after the market opened on Wednesday as an analyst at Oppenheimer published a particularly bearish take, arguing that the stock, which closed Tuesday at $22.